Advice4u.com

Dynavax Awarded NIH Grant To Explore Feasibility Of Universal Papilloma Virus Vaccine

July 7, 2010 – 11:21 pm

Dynavax Technologies Corporation (NASDAQ: DVAX) today announced the award of a $600,000 grant from the National Institutes of Health (NIH) to explore the feasibility of developing a universal vaccine to prevent infection by human papilloma virus (HPV). In contrast to the two approved HPV vaccines that target approximately 70 percent of HPV strains, Dynavax’s goal is to develop a vaccine that provides immunity to nearly all cancer-causing strains of HPV. Each year, 470,000 cervical cancers are diagnosed worldwide, and 250,000 deaths are due to cervical cancers…

Find more info about Dynavax Awarded NIH Grant To Explore Feasibility Of Universal Papilloma Virus Vaccine photos videos pictures. read more

Related Info :

Tags: Awarded, cancer, Cervical Cancers, Deaths, Dvax, Dynavax, Explore, Feasibility, Grant, Hpv Strains, Human Papilloma Virus, Human Papilloma Virus Hpv, Human Virus, immunity, Institutes Of Health, Nasdaq, National Health, National Institutes Of Health, National Institutes Of Health Nih, Nih, Papilloma, Papilloma Virus Vaccine, Photos Pictures, Universal, vaccine, Vaccines, Virus, Virus Pictures